StockData
INSMED Inc logo

INSMED Inc (INSM) income statement

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$119.80−2.06 (-1.69%)

Close on Nov 18, 2026Market cap $26.28BP/E –Yield –

INSMED Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
84.4%
Operating margin
-37.1%
Net margin
-39.9%
Return on equity, FY2025
-249.3%

Financial strength

Current ratio
2.86
Debt to equity
0.76
Debt to assets
24.9%
Cash to current liabilities
66.5%

Valuation

P/E ratio
–
Price to sales
17.29
Price to book
36.19
Dividend yield
–

See a number that looks wrong?